Public recall detail

GSK recalls two lots of migraine medication: IMITREX Injection

medium
Recall Safety notice
Quick summary

Quick summary: GSK recalls two lots of migraine medication: IMITREX Injection .

Recommended action

Recommended action: compare your product with the official notice and follow the instructions published by the official source.

Recall details

Quick summary: GSK recalls two lots of migraine medication: IMITREX Injection .

Official details

Affected product details

Structured information extracted from the official recall notice. Confirm the identifiers and instructions in the original notice.

Brand

Issue

GlaxoSmithKline Inc., in consultation with Health Canada, is voluntarily recalling two lots of “IMITREX Injection”, a migraine medication packaged in pre-filled syringes with an accompanying sterile needle for injection. The needles come with plastic shields that are designed to keep them free of contamination. Needles in the affected lots may be protruding through the needle shield. The protruding needle is no longer sterile and as such, there is a potential risk of infection to consumers when using the product.

What you should do

  • Patients who have IMITREX injection from the affected lots should not use the product, and should return it to their pharmacist.
  • If you have used IMITREX injection in the past three months, contact your healthcare professional.
  • Report any adverse events using this product to Health Canada.
  • Contact GSK Inc. at 1-800-387-7374 for more information about returning the product.
Additional official information
Background{}
Companies
Audiences

Contains information licensed under the Open Government Licence – Canada. SafetyPulse is independent of the Government of Canada.

Official source Monitor products Back to recalls

Starting...

Related recalls

Similar recalls and safety notices.

Loading related recalls...